[1]
“Cost Utility Analysis of BPJS and Non-BPJS Dyspepsia Patients Combination of Ranitidine Antacids with Lansoprazole Antacids”, J Keskom, vol. 8, no. 2, pp. 352–361, Aug. 2022, doi: 10.25311/keskom.Vol8.Iss2.1234.